ATORVASTATIN MEPHA cpr pell 10 mg bte 100 pce

7680693140035 CH-69314 C10AA05 07.12.0.

Active substances:

ATORVASTATIN MEPHA cpr pell 10 mg bte 100 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6931401
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
Filmtablette: atorvastatinum 10 mg ut atorvastatinum calcicum, cellulosum microcristallinum, calcii carbonas, maltosum, carmellosum natricum conexum, polysorbatum 80, magnesii aluminometasilicas, magnesii stearas, Überzug: hypromellosum, hydroxypropylcellulosum, triethylis citras, polysorbatum 80, E 171, pro compresso obducto corresp. natrium max. 0.41 mg.

Articles (1)

Atorvastatin-Mepha 10 mg, Filmtabletten
Filmtabletten
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
27/06/2026
Professional SmPC
Français
27/06/2026
Professional SmPC
Italien
27/06/2026
Patient information leaflet
Allemand
20/08/2025
Patient information leaflet
Français
20/08/2025
Patient information leaflet
Italien
20/08/2025

Detailed composition

Substance Quantity Type Category
atorvastatinum
10.0 MG Substance Wirkstoff (Principe actif)
atorvastatinum calcicum
- Substance WIZUS
cellulosum microcristallinum
- Substance HNIDK
calcii carbonas
- Substance HNIDK
maltosum
- Substance HNIDK
carmellosum natricum conexum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
magnesii aluminometasilicas
- Substance HNIDK
magnesii stearas
- Substance HNIDK
hypromellosum
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
triethylis citras
- Substance HNIDK
polysorbatum 80
- Substance HNIDK
E 171
- Substance FNIDK
natrium
- Substance HBESI

Reimbursement information

Public price
CHF 62.90
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/08/2025

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
69314
Drug name
Atorvastatin-Mepha, Filmtabletten
Galenic form
FILM
ATC Code
C10AA05
Authorization status
Z
Dispensation category
B
First authorization
21/08/2024
Authorization expiration date
20/08/2029
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
ATORVASTATIN MEPHA cpr pell 10 mg bte 100 pce
Description (DE)
ATORVASTATIN MEPHA Filmtabl 10 mg Ds 100 Stk
Market launch
01/08/2025
Narcotic (BTM)
No

Original drug

Sortis, Filmtabletten
CHF 37.75
View original

Other packaging sizes

ATORVASTATIN MEPHA cpr pell 10 mg 30 pce
30 TABL
View
ATORVASTATIN MEPHA cpr pell 10 mg 90 pce
90 TABL
View
ATORVASTATIN MEPHA cpr pell 20 mg 30 pce
30 TABL
View
ATORVASTATIN MEPHA cpr pell 20 mg 90 pce
90 TABL
View
ATORVASTATIN MEPHA cpr pell 20 mg bte 100 pce
100 TABL
View
ATORVASTATIN MEPHA cpr pell 40 mg 30 pce
30 TABL
View
ATORVASTATIN MEPHA cpr pell 40 mg 90 pce
90 TABL
View
ATORVASTATIN MEPHA cpr pell 40 mg bte 100 pce
100 TABL
View
Buy us a coffee Explore the data